EDITORIAL SECTION

  • STRATEGY

    Smarter Pharma

    Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products

  • EXPERT Talk

    Navigating the AI Transformation in Healthcare

    Real Chemistrys expansion into Zurich is part of our broader objective to help clients by scaling internationally while maintaining a local mindset We are bringing our connected capabilities to one of Europes most influential hotspots sitting at the intersection of science innovation and investment This convergence is ideal for collaboration

KNOWLEDGE BANK

  • Articles

    Acquisitions of Small-Medium Pharma Companies in EU

    In EU the middleclass in Pharma is disappearing companies with revenues by M with a small factory and operations limited to some few countries

    Digital Health and Wearables: Integration with Pharmaceuticals for Improved Patient Outcomes

    Digital health is the application of telecommunication technologies that allow people to control and maintain their health through their smartphone applications sensors and the cloud Mobile devices are while not the only ones an important factor in this digital health environment wearable fitness smart watches and health monitoring devices occupy this niche These wearables can track things as si...

    Pre-Formulation Studies and Analytical Techniques in Pharmaceutical Formulation Development

    Development of pharmaceutical formulations is a very important phase in the drug development process which lies between a drug molecule that is discovered and a dose form that can be commercially developed It is a process that involves designing optimizing and validating drug products to make sure that they are safe effective and able to be taken by patients Preformulation studies form a significa...

    Virtual Webinars for Pharma Lead Generation: B2B Strategies 2026

    In the changing environment of pharmaceutical marketing digital interactions have acquired the first place Although traditional facetoface conferences and trade show remain important virtual conferences are replacing them and at times complementing them Of them the pharma webinars have proven to be an effective approach to BB lead generation so pharmaceutical companies can connect with the audienc...

    How Cloud Computing and AI Revolutionize Pharmaceutical Supply Chain Management

    The pharma supply chain management has been considered as one of the most complicated spheres of operations in any industry As opposed to the traditional supply chain pharmaceutical supply chains have to juggle patient safety regulatory compliance cold chain integrity global sourcing and unpredictable demand and cost pressures simultaneously

    How Drug Patents Shape the Competitive Landscape in Pharma?

    It can rightly be said that the business of pharmaceuticals is very sensitive and crucial since business is all about the manufacturing of change for the purpose of ridding the world of diseases

TOP ARTICLES

press releases Read more...

Cytovance Biologics Expands Process Development Services with Perfusion Capabilities

Cytovance Biologics a leading USbased contract development and manufacturing organization CDMO serving the biopharmaceutical industry today announced the expansion of its upstream process development offerings with the addition of perfusion capabilities

Anova and Nouveau Biosciences Announce Partnership to Deliver Clinical Trials of Kromastat for the Treatment of Relapsed or Refractory Cutaneous and Peripheral T-Cell Lymphoma

Anova Enterprises Inc Anova a technology enabled CRO dedicated to accelerating promising treatments today announced its partnership with Nouveau Biosciences Inc to conduct cancer focused

Gerresheimer Commissions Photovoltaic System in Pfreimd

Gerresheimer an innovative system and solution provider and a global partner for the pharma biotech and cosmetic industries has successfully commissioned a photovoltaic system at its Pfreimd site following

Ligand Completes Acquisition of XOMA Royalty, Creating a Portfolio of More than 200 Biopharmaceutical Royalty Assets

Ligand Pharmaceuticals Incorporated Nasdaq LGND today announced it has completed its acquisition of XOMA Royalty Corporation XOMA Royalty a biotechnology royalty aggregator for per

16 - 19

Jul 2026

Bio Asia Taiwan 2026

Taipei Nangang Exhibition Cent...

20 - 22

Jul 2026

6th mRNA-Based Therapeutics Summit

The Westin Boston Seaport Dist...

20 - 22

Jul 2026

24 - 25

Jul 2026

26 - 30

Jul 2026

ADLM 2026

Anaheim, CA USA

27 - 28

Jul 2026

27 - 28

Jul 2026

27 - 28

Jul 2026

LATEST NEWS Read more...

Sinopia Biosciences Publishes Preclinical Study Supporting SB-0110 for Parkinson's Disease

Sinopia Biosciences has published preclinical research in Science Translational Medicine highlighting a new approach to treating Parkinsons disease The study supports the development of SB

Kairos Pharma Reports Positive Interim Safety Results from Phase 1 Trial of ENV-105 in EGFR-Mutated Lung Cancer

Kairos Pharma has reported positive interim safety results from its ongoing Phase clinical trial of ENV carotuximab in combination with osimertinib Tagrisso for patients with advanced EGFRmutated nonsmall cell lung cancer NSCLC

FDA Grants Priority Review to Roche’s Gazyva/Gazyvaro for Primary Membranous Nephropathy

Roche has announced that the US Food and Drug Administration FDA has granted Priority Review to its supplemental Biologics License Application sBLA for GazyvaGazyvaro obinutuzumab as a treatment

FDA Grants Fast Track Designation to SOTIO’s SOT109 for Advanced Colorectal Cancer

SOTIO Biotech has received Fast Track Designation FTD from the US Food and Drug Administration FDA for SOT its investigational antibodydrug conjugate ADC for the treatment of patients

Armata Pharmaceuticals Secures FDA Agreement on Initial Paediatric Study Plan for AP-SA02

Armata Pharmaceuticals has received agreement from the US Food and Drug Administration FDA on its Initial Paediatric Study Plan iPSP for APSA supporting the future evaluation of the investigational

DA Approves LEQEMBI IQLIK Subcutaneous Injection for Early Alzheimer’s Disease Treatment

Eisai and Biogen have received approval from the US Food and Drug Administration FDA for a supplemental Biologics License Application sBLA for LEQEMBI IQLIK lecanemabirmb a onceweekly subcutaneous injection for the initiation treatment of early Alzheimers disease